© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - OPKO Health Acquires EirGen Pharma
Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography
Image

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Building a Successful Upskilling Strategy
Strategy
21/12/2020Building a Successful Upskilling Strategy

How can businesses better support L&D in their organisations and build effective upskilling strategies to remain competitive?

Read Full PostRead - Eye Icon
Innovative Leaders:    My Controller
Finance
18/03/2015Innovative Leaders: My Controller

We spoke to Greg Parrish, Director of accountancy and tax practice, My Controller, to find out more about his company, the UK business environment and his secrets for success.

Read Full PostRead - Eye Icon
Hogan Lovells Advise Mapfre’s Acquisition of Direct Line
Finance
30/07/2015Hogan Lovells Advise Mapfre’s Acquisition of Direct Line

Hogan Lovells Advise Mapfre's Acquisition of Direct Line

Read Full PostRead - Eye Icon
Fairly and Forcefully Represented
Legal
09/10/2017Fairly and Forcefully Represented

Fairly and Forcefully Represented

Read Full PostRead - Eye Icon
The Most Common Questions On Personal Injury Claims Answered
Legal
24/03/2022The Most Common Questions On Personal Injury Claims Answered

For most of us, legal procedures and processes aren’t everyday occurrences: we see more of a courtroom through our TVs, as per Collider.com, than we ever do in person. Some of the most common circumstances in which people find themselves actually represented

Read Full PostRead - Eye Icon
Driven By Efficiency
M&A
07/12/2022Driven By Efficiency

For businesses looking to elevate themselves in any area, they must completely understand their clients’ demands as well as how to meet them.

Read Full PostRead - Eye Icon
Is Facebook Advertising the Right Choice for your Business?
News
29/11/2022Is Facebook Advertising the Right Choice for your Business?

No matter the industry in which your business operates, social media can act as an extremely powerful marketing tool, allowing you to expand your reach and connect with customers who may not have known about your brand otherwise.

Read Full PostRead - Eye Icon
Over a Third of International Employers Do Not Offer Enough Health and Wellbeing Benefits and This Impacts Their Recruitment and Retention
News
12/03/2025Over a Third of International Employers Do Not Offer Enough Health and Wellbeing Benefits and This Impacts Their Recruitment and Retention

In research issued by Towergate Employee Benefits, over a third (37%) of companies with employees based outside of the UK stated that they do not offer enough health and wellbeing support and that this impacts their ability to recruit and retain people.

Read Full PostRead - Eye Icon
5 Essentials Of An Effective Equipment Budget
Finance
27/03/20235 Essentials Of An Effective Equipment Budget

Are you a business owner planning to invest in equipment for efficient service and product delivery to your clients? What plans do you have in place to actualize the dream?



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow